bioecon Member area
Technology · Health & biomedicine / Diagnostics & medtech

CMOS High-Density Microelectrode Array (HD-MEA) Biochips

Silicon Complementary Metal-Oxide-Semiconductor (CMOS) microelectrode array biochips integrating tens of thousands of platinum or titanium-nitride microelectrodes at cellular and subcellular pitch, recording extracellular action potentials from single axons and dendrites in living human neural networks.

1 · What it gives

CMOS High-Density Microelectrode Array (HD-MEA) Biochips constitutes the biophysical and engineering backbone of modern cell and gene therapy manufacturing, providing automated, closed, and digitally monitored hardware platforms for bioprocess intensification. By replacing open manual handling with automated fluidic systems, acoustic radiation standing waves, high-gradient magnetic sorting, and non-invasive dielectric sensors, the platform eliminates environmental contamination risks and operator-induced variability. These systems ensure stringent compliance with cGMP Grade A/B aseptic boundary standards while significantly lowering cleanroom footprint requirements.

The technological spectrum integrates single-use fluidic cassettes, ultrasonic transducer arrays, automated peristaltic and syringe metering pumps, and optical/electrical biosensors. Closed-loop process control algorithms process multi-frequency impedance and dissolved oxygen metrics in real time, dynamically modulating perfusion exchange rates, nutrient addition, and harvest timing. Hardware and embedded software are validated under strict GAMP 5 and FDA 21 CFR Part 11 guidelines, guaranteeing unalterable audit trails, electronic signatures, and deterministic batch-to-batch repeatability.

The key directions of this technology are:

  1. Closed-Loop Fluidic Automation & Disposable Cassettes in CMOS High-Density Microelectrode Array (HD-MEA) Biochips: Designing gamma-irradiated single-use fluidic circuits that eliminate cross-contamination, clean-in-place (CIP), and sterilize-in-place (SIP) downtime between consecutive patient batches.
  2. Acoustic & Magnetic Gentle Cell Manipulation: Employing ultrasonic standing wave radiation forces or paramagnetic nano-beads to achieve rapid, non-destructive cell concentration, retention, and washing without membrane shear stress.
  3. In-Line Real-Time Process Analytical Technology (PAT): Embedding non-invasive multi-wavelength optical and dielectric spectroscopy sensors to continuously monitor biomass accumulation, cell viability, and metabolic flux.
  4. Digital Integrity & Automated Batch Release Systems: Implementing GAMP 5-compliant firmware architectures supporting automated electronic batch records (eBR) and encrypted supervisory control and data acquisition (SCADA).

Sectoral value chain#

┌────────────────────────────────────────────────────────┐
│  Tier 1: Precision Machining & Sensor Component Fab    │
│  (Ultrasonic PZT transducers, gold electrode arrays)   │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 2: Single-Use Cassette Injection & Assembly      │
│  (Medical-grade polymer moulding, gamma sterilization) │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 3: Closed-System Bioprocess Execution & Actuation│
│  (Peristaltic pumping, acoustic retention, cell wash)  │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 4: In-Line PAT Sensing & Adaptive Process Control│
│  (Multi-frequency impedance, pH/DO optical logging)    │
└───────────────────────────────────┬────────────────────┘
                                    │
                                    ▼
┌────────────────────────────────────────────────────────┐
│  Tier 5: 21 CFR Part 11 Electronic Batch Release       │
│  (Encrypted audit trail, automated QC parameter check) │
└────────────────────────────────────────────────────────┘

Value chain levels#

LevelDescriptionKey inputs/outputs
Precision Component ManufacturingFabrication and ISO 9001 qualification of acoustic piezo-transducers, optical read heads, and metering drives.In: Piezoelectric ceramics, optical diodes, medical alloys.
Out: Calibrated instrumentation hardware modules.
Single-Use Manifold AssemblyInjection molding and cleanroom assembly of biocompatible disposable tubing and fluidic cassettes.In: Medical-grade USP Class VI silicone, polypropylene.
Out: Sterile, gamma-irradiated single-use fluidic kit (<0.125 EU/mL).
Automated Bioprocess ExecutionClosed fluid handling, automated cell washing, acoustic concentration, and high-efficiency medium exchange.In: Cell suspension, GMP process buffers, disposable cassette.
Out: Concentrated, washed, and viably retained cell product (>95% recovery).
In-Line PAT Data LoggingContinuous acquisition of optical density, dielectric permittivity, and impedance spectra during active runs.In: Sensor signals, real-time feedback controllers.
Out: Real-time process trajectory data and automated parameter adjustment.
Electronic Batch Record QualificationAutomated verification of process limits, tamper-evident data signing, and cGMP electronic batch release.In: Run telemetry, automated eBR software, digital signatures.
Out: Released, fully audited clinical biomanufacturing run dossier.

Cross-cutting technologies of the sector:

  • Dielectric Spectroscopy (Capacitance) Monitoring: Non-invasive real-time tracking of viable cell volume fraction, unaffected by cell debris or microcarriers.
  • GAMP 5 Embedded Firmware Validation: Rigorous automated qualification ensuring total data integrity, traceability, and 21 CFR Part 11 compliance.

2 · What it replaces 3 · matched by industry

3 · How to implement 4 steps

  1. 1
    Monolithic CMOS integrated circuit fabrication
    Manufacturing custom mixed-signal silicon chips integrating analog amplification and multiplexed digitizers beneath electrode arrays.
  2. 2
    Subcellular pitch electrode metallization
    Depositing corrosion-resistant porous platinum black or titanium nitride electrodes with sub-10 µm inter-electrode spacing.
  3. 3
    Biocompatible surface encapsulation
    Passivating chip perimeters with medical-grade biocompatible epoxies resistant to chronic saline culture immersion at 37°C.
  4. 4
    Axonal propagation velocity mapping
    Tracking single-axon action potential velocity trajectories (0.2 to 1.5 m/s) with sub-millisecond temporal resolution.

4 · Who delivers

Matched suppliers (matched automatically)

Oenon HoldingsJapanProduceractive
Great Lakes Bio Systems, Inc.United StatesProduceractive
Kingsford Environmental (HK) LTDHong KongServices / consultingactive
Kolon IndustriesSouth KoreaProduceractive
Bluepha 蓝晶微生物ChinaProduceractive
Alborz Co.IranProduceractive
Agromec sarl - MEAFLebanonProduceractive
SustenirSingaporeProduceractive
Bukoola Chemical Industries LtdUgandaDistributoractive
Omni EcosystemsUnited StatesProduceractive
SKC Co., Ltd. (SK Group)South KoreaProduceractive

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Miltenyi Biotec🇩🇪 GermanyCliniMACS Prodigy Automated ProcessingStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Lonza Cell & Gene🇨🇭 SwitzerlandCocoon Closed Manufacturing PlatformStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Cytiva🇺🇸 United StatesXuri Cell Expansion Bioreactors & SefiaStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
WuXi Advanced Therapies🇨🇳 ChinaViral Vector Testing & Analytical DevelopmentStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Sartorius Stedim Biotech🇩🇪 GermanyAmbr Bioreactors & Process PAT SystemsStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved
Thermo Fisher Scientific🇺🇸 United StatesGibco CTS Cell Therapy MediaStandardized cGMP ATMP bioprocess module and validated analytical release assay suite.Commercial / Approved

5 · Rules & route to market

Route into Russia / EAEU: EAC · EAEU accredited bodies / Rosakkreditatsiya
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

FDA CDER/CBER advanced manufacturing framework, GAMP 5, USP standards#

  • FDA Advanced Manufacturing Technologies (AMT) Designation: Expedited qualification pathways for innovative bioprocess equipment under CMOS High-Density Microelectrode Array (HD-MEA) Biochips.
  • GAMP 5 Software Compliance: Strict lifecycle documentation and computerized system validation across US cell therapy manufacturing centers.
  • Single-Use System Standards (BPOG/BPSA): Adherence to extractables and leachables (E&L) testing guidelines standardizing disposable fluidics.

European Union

EMA Annex 1 revision (sterile manufacturing), CE/IVDR certification#

  • EU GMP Annex 1 Compliance: Enforcing closed isolator systems, automated monitoring, and continuous contamination control strategies (CCS).
  • CE Marking & Electromagnetic Compatibility (EMC): Rigorous safety, electrical, and biomedical device qualification across European clinical suites.
  • Swiss Precision Engineering Partnerships: Deep collaboration with Swiss and German high-precision fluidic pump and sensor manufacturers.

China

National high-end medical equipment plans, NMPA GMP guidelines, cleanroom hubs#

  • Domestic Substitution of High-End Bioprocess Equipment: State-level policies prioritizing domestic automated cell therapy bioreactors and sorters for 互补金属氧化物半导体(CMOS)超高密度微电极阵列生物芯片(HD-MEA).
  • NMPA Annex for Advanced Therapy Medicinal Products: Specific regulatory requirements for closed systems, automated isolation, and sterile consumables.
  • Precision Instrument Clusters: Rapidly expanding high-precision biomedical hardware hubs across Shenzhen, Suzhou, and Hangzhou.

6 · Money: tenders & grants

7 · Tech stack & innovations

  1. Fluidic & Physical Actuation Engine in CMOS High-Density Microelectrode Array (HD-MEA) Biochips:
    • Acoustic standing-wave resonators generating gentle primary radiation forces for shear-free cell focus and separation.
    • High-precision multi-channel peristaltic or syringe metering drives with accuracy exceeding ±1.5% at micro-liter flow rates.
  2. Sterile Single-Use Fluidic Architecture:
    • Thermoplastic elastomer (TPE) weldable tubing manifolds enabling sterile closed-system dockings.
    • Hydrophobic PTFE venting membranes ensuring sterile pressure equalization without aerosol release.
  3. Embedded In-Line Process Analytics:
    • Multi-frequency impedance spectroscopy cells tracking cellular membrane polarization and size distribution.
    • Non-invasive optical reflectance patches reading dissolved oxygen and pH without culture fluid contact.

Sources 1 · 0 independent · 1 producer sites

Producers' own sites 1

  1. www.swissbiotech.org producer checked 2026-11-22